These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 3010154)

  • 1. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships of opioidergic and adrenergic mechanisms controlling the secretion of corticotrophin releasing factor in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1987 Sep; 46(3):199-206. PubMed ID: 2821423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat.
    Cover PO; Buckingham JC
    J Endocrinol; 1989 May; 121(2):213-20. PubMed ID: 2547002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.
    Buckingham JC
    Neuroendocrinology; 1982; 35(2):111-6. PubMed ID: 6290921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of the hypothalamo-pituitary-adrenocortical axis in the rat after long-term dexamethasone treatment.
    Nicholson S; Campbell E; Torrellas A; Beckford U; Altaher R; Sandford R; Scraggs R; Gillham B; Jones M
    Neuroendocrinology; 1984 Oct; 39(4):343-9. PubMed ID: 6092989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
    Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
    J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase activity is necessary for hypothalamo-pituitary-adrenal (HPA) responses to ether, and stress-induced facilitation of subsequent HPA responses to acute ether emerges as HPA responses are inhibited by increasing corticosterone (B).
    Murakami K; Akana SF; Dallman MF
    J Neuroendocrinol; 1997 Aug; 9(8):601-8. PubMed ID: 9283048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
    Stark E; Kárteszi M; Rappay G; Makara GB
    J Endocrinol; 1981 Jan; 88(1):131-9. PubMed ID: 6257818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alpha-adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat.
    Suemaru S; Dallman MF; Darlington DN; Cascio CS; Shinsako J
    Neuroendocrinology; 1989 Feb; 49(2):181-90. PubMed ID: 2542829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N; Shibasaki T; Wakabayashi I; Demura H
    Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal alteration in opiate effects on the hypothalamo-pituitary-adrenal axis: changes in the mechanism of action.
    Kiem DT; Fekete MI; Makara GB
    Eur J Pharmacol; 1995 Jan; 272(2-3):145-50. PubMed ID: 7713158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.